Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Model illuminates roles of mononuclear phagocyte subsets in renal disease

Oct. 4, 2021

Potent inhibitor of sAC shows potential as nonhormonal contraceptive

Sep. 27, 2021

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Sep. 22, 2021

IP6K regulates circulating phosphate and intracellular ATP in mammals

Sep. 20, 2021

Combined inhibition of RIPK1 and ferroptosis as potential therapeutic strategy for AKI

Sep. 13, 2021

Opaganib significantly decreases kidney fibrosis in in vivo model

Sep. 8, 2021

4-PBA and TUDCA reduce symptoms in murine model of Alport syndrome

Sep. 7, 2021

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

Aug. 26, 2021

Serodus initiates phase II/III study of SER-150 in diabetic kidney disease

Aug. 25, 2021

First patient enrolled in trial on sirolimus drug-eluting balloon for erectile dysfunction

Aug. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...